215 related articles for article (PubMed ID: 37400766)
1. Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study.
Liu Y; Feng J; Ren Y; Shi W; Kang H; Peng Y; Tan Y; Wu R; Zhang G; He Y
BMC Ophthalmol; 2023 Jul; 23(1):297. PubMed ID: 37400766
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
[TBL] [Abstract][Full Text] [Related]
3. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Ueta M
Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
[No Abstract] [Full Text] [Related]
4. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
5. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
6. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
7. Topical Betamethasone Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Involvement in the Acute Phase.
Matsumoto K; Ueta M; Inatomi T; Fukuoka H; Mieno H; Tamagawa-Mineoka R; Katoh N; Kinoshita S; Sotozono C
Am J Ophthalmol; 2023 Sep; 253():142-151. PubMed ID: 37182731
[TBL] [Abstract][Full Text] [Related]
8. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K;
Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Kwan J; Ahmed H; Ponsetto MK; Succar T; Chodosh J; Saeed HN
Ocul Immunol Inflamm; 2023 Jul; 31(5):900-904. PubMed ID: 35486647
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid Pulse Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Patients With Acute Ocular Involvement.
Mieno H; Ueta M; Kinoshita F; Teramukai S; Kinoshita S; Sotozono C
Am J Ophthalmol; 2021 Nov; 231():194-199. PubMed ID: 34214456
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.
Ueta M
Front Med (Lausanne); 2021; 8():651247. PubMed ID: 34869401
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea.
Lee HS; Ueta M; Kim MK; Seo KY; Sotozono C; Kinoshita S; Yoon KC
Cornea; 2016 Feb; 35(2):199-204. PubMed ID: 26655481
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Assessment of Long-Term Complications in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Cekic S; Canitez Y; Yuksel H; Ucan Gunduz G; Karali Z; Yalcinbayir O; Vural P; Sapan N
Int Arch Allergy Immunol; 2023; 184(10):994-1002. PubMed ID: 37494888
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y
Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432
[TBL] [Abstract][Full Text] [Related]
17. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
18. Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement.
Thorel D; Ingen-Housz-Oro S; Royer G; Delcampe A; Bellon N; Bodemer C; Welfringer-Morin A; Bremond-Gignac D; Robert MP; Tauber M; Malecaze F; Dereure O; Daien V; Colin A; Bernier C; Couret C; Vabres B; Tetart F; Milpied B; Cornut T; Ben Said B; Burillon C; Cordel N; Beral L; de Prost N; Wolkenstein P; Muraine M; Gueudry J
Orphanet J Rare Dis; 2020 Sep; 15(1):259. PubMed ID: 32962748
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage.
Ueta M; Nishigaki H; Sotozono C; Kinoshita S
BMJ Open Ophthalmol; 2017; 1(1):e000073. PubMed ID: 29354711
[TBL] [Abstract][Full Text] [Related]
20. Acute and Chronic Ophthalmic Involvement, Severity, and Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Ganekal S; Nagarajappa A
Korean J Ophthalmol; 2021 Jun; 35(3):179-187. PubMed ID: 33596622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
